Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of VISTABEL (20 units) vs Bocouture (30 units) for glabellar lines
2010-021401-20Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in glabellar furrowing (2 arms), sponsored by AbbVie Inc. Started Sep 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on 2010-021401-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021401-20.